<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1404</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10201917</PubmedId>
            <Abstract>One of the most remarkable features of the MHC class I loci of most outbred mammalian populations is their exceptional diversity, yet the functional importance of this diversity remains to be fully understood. The cotton-top tamarin (Saguinus oedipus) is unusual in having MHC class I loci that exhibit both limited polymorphism and sequence variation. To investigate the functional implications of limited MHC class I diversity in this outbred primate species, we infected five tamarins with influenza virus and defined the CTL epitopes recognized by each individual. In addition to an immunodominant epitope of the viral nucleoprotein (NP) that was recognized by all individuals, two tamarins also made a response to the same epitope of the matrix (M1) protein. Surprisingly, these two tamarins used different MHC class I molecules, Saoe-G*02 and -G*04, to present the M1 epitope. In addition, CTLs from one of the tamarins recognized target cells that expressed neither Saoe-G*02 nor -G*04, but, rather, a third MHC class I molecule, Saoe-G*12. Sequence analysis revealed that Saoe-G*12 differs from both Saoe-G*02 and -G*04 by only two nucleotides and was probably generated by recombination between these two alleles. These results demonstrate that at least three of the tamarin's MHC class I molecules can present the same epitope to virus-specific CTLs. Thus, four of the tamarin's 12 MHC class I molecules bound only two influenza virus CTL epitopes. Therefore, the functional diversity of cotton-top tamarin's MHC class I loci may be even more limited than their genetic diversity suggests.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>3970-7</ArticlePages>
            <ArticleTitle>Three different MHC class I molecules bind the same CTL epitope of the influenza virus in a primate species with limited MHC class I diversity.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Evans</LastName>
                    <ForeName>D T</ForeName>
                </Author>
                <Author>
                    <LastName>Knapp</LastName>
                    <ForeName>L A</ForeName>
                </Author>
                <Author>
                    <LastName>Jing</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Piekarczyk</LastName>
                    <ForeName>M S</ForeName>
                </Author>
                <Author>
                    <LastName>Hinshaw</LastName>
                    <ForeName>V S</ForeName>
                </Author>
                <Author>
                    <LastName>Watkins</LastName>
                    <ForeName>D I</ForeName>
                </Author>
            </Authors>
            <Affiliations>Wisconsin Regional Primate Research Center, University of Wisconsin, Madison 53715, USA.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Histocompatibility Antigens Class I;M-protein, influenza virus;M1 protein, Influenza A virus;Viral Matrix Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Alleles; Amino Acid Sequence; Animals; Antigen Presentation(immunology); Cells, Cultured; Cytotoxicity, Immunologic(immunology); Epitopes, T-Lymphocyte(immunology; metabolism); Histocompatibility Antigens Class I(genetics; immunology; metabolism); Influenza A virus(immunology); Models, Molecular; Molecular Sequence Data; Orthomyxoviridae Infections(immunology); Saguinus(genetics; immunology; virology); T-Lymphocytes, Cytotoxic(immunology; metabolism); Tumor Cells, Cultured; Viral Matrix Proteins(immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>162</Volume>
                <Issue>7</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>M1 11a</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RKLKREITF</LinearSequence>
                        <StartingPosition>101</StartingPosition>
                        <EndingPosition>109</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q9IQ48.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>132504</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>54385</EpitopeId>
                <ReferenceStartingPosition>101</ReferenceStartingPosition>
                <ReferenceEndingPosition>109</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Epitope previously described as subdominant in the CTL responses against Influenza virus in the cotton-top tamarin (Sanguinus oedipus). Several strains of Influenza harbor this epitope.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 1&amp; 2, Figure 1</LocationOfData>
                        <TCellId>22112</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9490</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DOID:8469</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                                <DoseSchedule>10^6 egg 50% ID</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>PBMCs were drawn for CTL culture and cloning between 2 and 4 wk post infection. Infection was shown to be cleared by day 17 post infection.  Cultures and clones were stimulated in vitro with Influenza A/x31.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>485</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 11a</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKLKREITF</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>109</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q9IQ48.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The use of different MHC I stable transfectant target cells (human MHC-I negative B lymphoblastoid cell lines 721.221 or CR1)  allowed for the identification of 3 different alleles (Saoe-G*04, Saoe-G*02 and Saoe-G*12) as the presenting molecules for CTL lines and clones from 2 responsive virus infected animals. Sequence analysis of the MHC I alleles shows that these 3 molecules are very similar, particularly in the B pocket, which typically has the greatest influence on the peptide specificity of HLA-A and -B molecules. This similarities are also seen between other MHC allele groups in this host. A dependence of the immune response in the MHC binding from molecules with overlapping peptide specificities, in a species such this one, with limited MHC class I polymorphism and allelic variation, may explain the unusual lethality of virus infections in  captive tamarins.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 1&amp; 2, Figure 1</LocationOfData>
                        <TCellId>22111</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9490</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DOID:8469</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                                <DoseSchedule>10^6 egg 50% ID</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>PBMCs were drawn for CTL culture and cloning between 2 and 4 wk post infection.Infection was shown to be cleared by day 17 post infection.  Cultures and clones were stimulated in vitro with Influenza A/x31.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>483</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 11a</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKLKREITF</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>109</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q9IQ48.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The use of different MHC I stable transfectant target cells (human MHC-I negative B lymphoblastoid cell lines 721.221 or CR1)  allowed for the identification of 3 different alleles (Saoe-G*04, Saoe-G*02 and Saoe-G*12) as the presenting molecules for CTL lines and clones from 2 responsive virus infected animals. Sequence analysis of the MHC I alleles shows that these 3 molecules are very similar, particularly in the B pocket, which typically has the greatest influence on the peptide specificity of HLA-A and -B molecules. This similarities are also seen between other MHC allele groups in this host. A dependence of the immune response in the MHC binding from molecules with overlapping peptide specificities, in a species such this one, with limited MHC class I polymorphism and allelic variation, may explain the unusual lethality of virus infections in  captive tamarins.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 1&amp; 2, Figure 1</LocationOfData>
                        <TCellId>22106</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9490</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DOID:8469</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                                <DoseSchedule>10^6 egg 50% ID</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>132504</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>PBMCs were drawn for CTL culture and cloning between 2 and 4 wk post infection. Infection was shown to be cleared by day 17 post infection.  Cultures and clones were stimulated in vitro with Influenza A/x31.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>482</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>M1 11a</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKLKREITF</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>109</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q9IQ48.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>132504</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The use of different MHC I stable transfectant target cells (human MHC-I negative B lymphoblastoid cell lines 721.221 or CR1)  allowed for the identification of 3 different alleles (Saoe-G*04, Saoe-G*02 and Saoe-G*12) as the presenting molecules for CTL lines and clones from 2 responsive virus infected animals. Sequence analysis of the MHC I alleles shows that these 3 molecules are very similar, particularly in the B pocket, which typically has the greatest influence on the peptide specificity of HLA-A and -B molecules. This similarities are also seen between other MHC allele groups in this host. A dependence of the immune response in the MHC binding from molecules with overlapping peptide specificities, in a species such this one, with limited MHC class I polymorphism and allelic variation, may explain the unusual lethality of virus infections in  captive tamarins.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

